Free Trial

Curtiss-Wright (CW) Financials

Curtiss-Wright logo
$710.69 -2.03 (-0.29%)
Closing price 03:59 PM Eastern
Extended Trading
$710.49 -0.20 (-0.03%)
As of 04:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Curtiss-Wright

Annual Income Statements for Curtiss-Wright

This table shows Curtiss-Wright's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
145 187 215 276 308 201 263 294 355 405 484
Consolidated Net Income / (Loss)
145 187 215 276 308 201 263 294 355 405 484
Net Income / (Loss) Continuing Operations
192 189 215 276 308 201 263 294 355 405 484
Total Pre-Tax Income
275 268 300 356 396 263 349 389 463 522 620
Total Operating Income
311 297 325 374 404 289 377 423 485 529 634
Total Gross Profit
783 2,109 801 871 899 841 928 955 1,067 1,154 1,302
Total Revenue
2,206 2,109 2,271 2,412 2,488 2,391 2,501 2,557 2,845 3,121 3,498
Operating Revenue
2,206 2,109 2,271 2,412 2,488 2,391 2,501 2,557 2,845 3,121 3,498
Total Cost of Revenue
1,422 0.00 1,470 1,541 1,589 1,550 1,573 1,602 1,778 1,968 2,197
Operating Cost of Revenue
1,422 - 1,470 1,541 1,589 1,550 1,573 1,602 1,778 1,968 2,197
Total Operating Expenses
473 1,812 476 498 495 552 551 527 583 625 668
Selling, General & Admin Expense
412 379 414 433 422 413 443 446 497 519 568
Research & Development Expense
61 59 61 65 73 75 88 81 86 92 95
Restructuring Charge
- - - 0.00 0.00 32 - 0.00 0.00 14 4.50
Total Other Income / (Expense), net
-35 -29 -26 -17 -7.49 -26 -28 -39 -22 -6.54 -14
Interest Expense
36 41 41 34 31 36 40 47 51 45 43
Other Income / (Expense), net
0.62 13 16 17 24 9.75 12 8.08 30 38 30
Income Tax Expense
83 79 85 80 89 62 86 95 109 117 136
Basic Earnings per Share
$3.12 $4.22 $4.86 $6.28 $7.20 $4.83 $6.50 $7.67 $9.26 $10.61 $12.94
Weighted Average Basic Shares Outstanding
46.62M 44.39M 44.18M 43.89M 42.74M 41.74M 40.42M 38.39M 38.28M 38.15M 37.42M
Diluted Earnings per Share
$3.05 $4.15 $4.80 $6.22 $7.15 $4.80 $6.47 $7.62 $9.20 $10.55 $12.87
Weighted Average Diluted Shares Outstanding
47.62M 45.05M 44.76M 44.32M 43.02M 42.00M 40.60M 38.65M 38.53M 38.37M 37.63M
Weighted Average Basic & Diluted Shares Outstanding
46.60M 44.40M 44.20M 43.90M 42.71M 40.94M 38.44M 38.27M 38.21M 37.66M 36.87M
Cash Dividends to Common per Share
$0.52 $0.52 $0.56 $0.60 $0.66 $0.68 $0.71 $0.75 $0.79 $0.83 $0.93

Quarterly Income Statements for Curtiss-Wright

This table shows Curtiss-Wright's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
97 120 76 99 111 118 101 121 125 137 128
Consolidated Net Income / (Loss)
97 120 76 99 111 118 101 121 125 137 128
Net Income / (Loss) Continuing Operations
97 120 76 99 111 118 101 121 125 137 128
Total Pre-Tax Income
127 157 99 126 144 153 125 157 161 177 158
Total Operating Income
133 161 100 129 145 155 129 156 166 182 160
Total Gross Profit
281 305 254 284 298 317 292 326 327 355 331
Total Revenue
724 786 713 785 799 824 806 877 869 947 914
Operating Revenue
724 786 713 785 799 824 806 877 869 947 914
Total Cost of Revenue
443 481 459 501 501 507 513 550 542 592 582
Operating Cost of Revenue
443 481 459 501 501 507 513 550 542 592 582
Total Operating Expenses
149 144 154 155 153 163 163 170 161 174 172
Selling, General & Admin Expense
125 124 131 130 129 129 139 146 137 147 147
Research & Development Expense
23 20 23 22 21 26 23 23 23 25 24
Restructuring Charge
0.00 - 0.00 2.92 3.28 - 1.29 0.71 0.80 1.71 0.91
Total Other Income / (Expense), net
-5.47 -3.84 -0.96 -2.66 -1.28 -1.64 -4.11 0.46 -5.10 -4.76 -1.74
Interest Expense
12 11 11 11 11 12 10 11 10 12 9.94
Other Income / (Expense), net
7.02 7.12 9.61 8.56 10 10 6.03 11 5.39 7.24 8.20
Income Tax Expense
30 37 23 27 32 35 24 36 36 40 30
Basic Earnings per Share
$2.53 $3.14 $2.00 $2.60 $2.91 $3.10 $2.69 $3.21 $3.34 $3.70 $3.47
Weighted Average Basic Shares Outstanding
38.29M 38.28M 38.25M 38.30M 38.21M 38.15M 37.68M 37.69M 37.43M 37.42M 36.90M
Diluted Earnings per Share
$2.51 $3.11 $1.99 $2.58 $2.89 $3.09 $2.68 $3.19 $3.31 $3.69 $3.46
Weighted Average Diluted Shares Outstanding
38.56M 38.53M 38.43M 38.50M 38.45M 38.37M 37.85M 37.90M 37.66M 37.63M 37.06M
Weighted Average Basic & Diluted Shares Outstanding
38.24M 38.21M 38.30M 38.30M 37.95M 37.66M 37.69M 37.68M 36.87M 36.87M 36.94M
Cash Dividends to Common per Share
$0.20 $0.20 $0.20 $0.21 $0.21 $0.21 $0.21 $0.24 $0.24 $0.24 $0.24

Annual Cash Flow Statements for Curtiss-Wright

This table details how cash moves in and out of Curtiss-Wright's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-161 265 -79 -199 115 -193 -27 86 150 -22 -14
Net Cash From Operating Activities
162 423 389 336 421 261 388 295 448 544 643
Net Cash From Continuing Operating Activities
162 423 389 336 421 261 388 295 448 544 643
Net Income / (Loss) Continuing Operations
145 187 215 276 308 201 263 294 355 405 484
Consolidated Net Income / (Loss)
145 187 215 276 308 201 263 294 355 405 484
Depreciation Expense
101 96 100 103 102 116 114 112 116 108 125
Non-Cash Adjustments To Reconcile Net Income
66 6.56 11 0.12 2.62 72 32 15 14 23 22
Changes in Operating Assets and Liabilities, net
-150 133 64 -43 8.79 -129 -22 -127 -37 8.48 12
Net Cash From Investing Activities
-16 -43 -272 -256 -240 -533 -42 -326 -36 -283 -90
Net Cash From Continuing Investing Activities
-16 -43 -272 -256 -240 -533 -42 -326 -36 -283 -90
Purchase of Property, Plant & Equipment
-36 -47 -53 -53 -70 -47 -41 -38 -45 -61 -90
Acquisitions
-14 -0.86 -233 -210 -185 -488 0.00 -282 0.00 -226 0.00
Sale of Property, Plant & Equipment
2.28 3.67 6.77 9.12 15 2.93 4.05 9.84 9.15 3.21 1.27
Sale and/or Maturity of Investments
- - - - - - - - 0.00 0.00 7.92
Other Investing Activities, net
- - 6.24 -1.05 -0.17 -0.02 -5.34 -5.06 0.00 0.00 -9.62
Net Cash From Financing Activities
-289 -96 -214 -264 -68 82 -369 129 -273 -271 -578
Net Cash From Continuing Financing Activities
-289 -96 -214 -264 -68 82 -369 129 -273 -271 -578
Repayment of Debt
-79 -9.07 -159 -424 -39 -572 -463 -1,793 -842 -22 -566
Repurchase of Common Equity
-294 -105 -52 -199 -51 -200 -343 -57 -50 -250 -465
Payment of Dividends
-24 -23 -25 -26 -28 -28 -29 -29 -30 -32 -35
Issuance of Debt
70 7.84 7.66 373 38 871 456 1,998 638 21 475
Issuance of Common Equity
29 22 14 12 12 11 9.71 10.00 11 11 13
Effect of Exchange Rate Changes
-19 -19 19 -16 1.75 -3.52 -3.38 -12 11 -11 11

Quarterly Cash Flow Statements for Curtiss-Wright

This table details how cash moves in and out of Curtiss-Wright's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-9.93 258 -69 45 61 -59 -159 105 -106 146 -28
Net Cash From Operating Activities
146 282 -46 111 177 301 -39 137 193 353 -5.66
Net Cash From Continuing Operating Activities
146 285 -46 111 177 301 -39 136 193 353 -5.66
Net Income / (Loss) Continuing Operations
97 120 76 99 111 118 101 121 125 137 128
Consolidated Net Income / (Loss)
97 120 76 99 111 118 101 121 125 137 128
Depreciation Expense
29 29 27 27 27 27 31 31 31 31 28
Non-Cash Adjustments To Reconcile Net Income
4.50 3.46 4.72 6.23 7.32 4.89 5.78 3.80 13 -0.62 7.20
Changes in Operating Assets and Liabilities, net
16 132 -154 -22 32 152 -177 -20 24 185 -169
Net Cash From Investing Activities
-9.38 -3.95 -12 -45 -14 -213 -25 -12 -17 -37 -12
Net Cash From Continuing Investing Activities
-9.38 -3.95 -12 -45 -14 -213 -25 -12 -17 -37 -12
Purchase of Property, Plant & Equipment
-9.37 -13 -12 -11 -15 -23 -16 -19 -17 -38 -12
Acquisitions
- - 0.00 - - -192 -9.62 9.62 -9.62 9.62 0.00
Sale of Property, Plant & Equipment
-0.01 8.68 0.04 0.09 1.07 2.00 0.50 -0.20 0.12 0.84 0.31
Net Cash From Financing Activities
-141 -28 -7.01 -21 -115 -129 -99 -29 -282 -168 -8.01
Net Cash From Continuing Financing Activities
-141 -28 -7.01 -21 -115 -129 -99 -29 -282 -168 -8.01
Repayment of Debt
-230 -52 -5.17 -4.31 -8.02 -5.00 -168 -61 -122 -214 -69
Repurchase of Common Equity
-13 -13 -12 -13 -113 -112 -14 -21 -290 -140 -14
Issuance of Debt
105 52 4.88 4.01 7.72 4.69 78 61 132 204 69
Other Financing Activities, net
5.36 - 5.47 - 5.87 - 5.98 - 6.56 - 6.48
Effect of Exchange Rate Changes
-6.33 7.99 -4.18 -1.52 13 -18 3.65 9.34 0.05 -1.72 -2.71

Annual Balance Sheets for Curtiss-Wright

This table presents Curtiss-Wright's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
2,990 3,038 3,236 3,255 3,764 4,021 4,104 4,448 4,621 4,986 5,221
Total Current Assets
1,275 1,415 1,402 1,344 1,530 1,301 1,308 1,516 1,717 1,850 2,018
Cash & Equivalents
289 554 475 276 391 198 171 257 407 385 371
Accounts Receivable
566 463 495 594 632 589 647 723 733 835 932
Inventories, net
380 367 379 423 425 429 412 483 510 541 615
Other Current Assets
40 31 53 51 82 85 78 53 68 88 100
Plant, Property, & Equipment, net
414 389 390 375 386 378 360 343 333 339 382
Total Noncurrent Assets
1,301 1,234 1,444 1,537 1,849 2,342 2,436 2,590 2,571 2,797 2,821
Goodwill
973 951 1,096 1,088 1,167 1,455 1,463 1,545 1,559 1,676 1,692
Intangible Assets
311 271 330 430 480 610 538 621 558 597 532
Employee Benefit Assets
- - - - 0.00 93 256 223 262 299 334
Other Noncurrent Operating Assets
18 12 18 19 202 185 178 201 193 225 262
Total Liabilities & Shareholders' Equity
2,990 3,038 3,236 3,255 3,764 4,021 4,104 4,448 4,621 4,986 5,221
Total Liabilities
1,734 1,747 1,709 1,725 1,990 2,234 2,277 2,467 2,293 2,536 2,688
Total Current Liabilities
523 675 591 687 745 810 735 981 807 1,096 1,406
Short-Term Debt
1.26 151 0.15 0.24 0.00 100 0.00 203 0.00 90 200
Accounts Payable
163 178 185 233 222 201 212 267 244 247 310
Accrued Expenses
132 130 150 167 165 140 148 174 188 219 243
Current Deferred Revenue
182 170 215 237 276 253 260 255 304 459 561
Other Current Liabilities
37 28 36 45 74 99 103 83 71 80 91
Total Noncurrent Liabilities
1,211 1,071 1,118 1,037 1,245 1,423 1,542 1,486 1,486 1,440 1,282
Long-Term Debt
952 816 814 762 761 958 1,051 1,052 1,050 959 758
Noncurrent Deferred & Payable Income Tax Liabilities
54 50 49 47 80 115 147 123 132 141 154
Noncurrent Employee Benefit Liabilities
104 107 121 101 139 98 91 58 67 67 71
Other Noncurrent Operating Liabilities
87 85 119 111 106 103 112 240 236 273 299
Commitments & Contingencies
- - - - - - - 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,255 1,291 1,528 1,531 1,774 1,788 1,826 1,981 2,328 2,450 2,534
Total Preferred & Common Equity
1,255 1,291 1,528 1,531 1,774 1,788 1,826 1,981 2,328 2,450 2,534
Total Common Equity
1,255 1,291 1,528 1,531 1,774 1,788 1,826 1,981 2,328 2,450 2,534
Common Stock
194 179 170 167 165 172 176 184 189 197 214
Retained Earnings
1,591 1,755 1,944 2,191 2,497 2,670 2,909 3,163 3,488 3,861 4,311
Treasury Stock
-303 -351 -369 -540 -563 -744 -1,068 -1,107 -1,135 -1,365 -1,817
Accumulated Other Comprehensive Income / (Loss)
-226 -292 -217 -288 -325 -311 -190 -259 -213 -243 -174

Quarterly Balance Sheets for Curtiss-Wright

This table presents Curtiss-Wright's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
4,362 4,441 4,414 4,612 4,748 4,886 4,952 5,194 5,102 5,270
Total Current Assets
1,446 1,524 1,545 1,737 1,836 1,952 1,800 2,000 1,927 2,072
Cash & Equivalents
131 159 149 338 383 444 226 332 225 343
Accounts Receivable
720 752 790 777 817 858 911 962 977 996
Inventories, net
528 546 540 553 559 583 578 611 637 641
Other Current Assets
67 68 66 69 77 68 84 96 88 91
Plant, Property, & Equipment, net
340 341 335 329 327 330 350 360 364 379
Total Noncurrent Assets
2,576 2,577 2,534 2,546 2,585 2,603 2,802 2,835 2,811 2,819
Goodwill
1,549 1,556 1,547 1,552 1,571 1,583 1,674 1,699 1,693 1,685
Intangible Assets
605 590 572 542 545 532 583 570 550 516
Employee Benefit Assets
228 233 236 267 273 279 306 315 322 340
Other Noncurrent Operating Assets
194 198 179 184 196 208 239 252 246 277
Total Liabilities & Shareholders' Equity
4,362 4,441 4,414 4,612 4,748 4,886 4,952 5,194 5,102 5,270
Total Liabilities
2,308 2,303 2,229 2,232 2,290 2,395 2,393 2,483 2,573 2,638
Total Current Liabilities
672 721 775 858 897 987 954 1,027 1,101 1,360
Short-Term Debt
0.00 0.00 0.00 90 90 90 0.00 0.00 0.00 200
Accounts Payable
208 234 214 234 225 223 238 261 270 277
Accrued Expenses
154 144 189 158 159 194 181 179 228 203
Current Deferred Revenue
234 265 293 298 342 392 448 500 504 569
Other Current Liabilities
76 78 81 79 82 87 87 86 100 111
Total Noncurrent Liabilities
1,636 1,582 1,453 1,374 1,393 1,409 1,439 1,456 1,471 1,278
Long-Term Debt
1,230 1,176 1,051 960 960 959 959 958 969 758
Noncurrent Deferred & Payable Income Tax Liabilities
123 118 117 128 128 124 139 145 145 160
Noncurrent Employee Benefit Liabilities
58 58 58 67 68 68 68 70 74 69
Other Noncurrent Operating Liabilities
212 216 214 205 224 242 272 283 284 292
Commitments & Contingencies
- - - - - - - - - 0.00
Total Equity & Noncontrolling Interests
2,054 2,138 2,185 2,380 2,458 2,490 2,559 2,712 2,529 2,632
Total Preferred & Common Equity
2,054 2,138 2,185 2,380 2,458 2,490 2,559 2,712 2,529 2,632
Total Common Equity
2,054 2,138 2,185 2,380 2,458 2,490 2,559 2,712 2,529 2,632
Common Stock
176 180 186 182 185 194 194 199 210 212
Retained Earnings
3,224 3,297 3,376 3,557 3,648 3,751 3,954 4,066 4,182 4,430
Treasury Stock
-1,101 -1,114 -1,123 -1,130 -1,141 -1,251 -1,365 -1,385 -1,677 -1,816
Accumulated Other Comprehensive Income / (Loss)
-244 -225 -253 -228 -233 -203 -224 -168 -186 -194

Annual Metrics And Ratios for Curtiss-Wright

This table displays calculated financial ratios and metrics derived from Curtiss-Wright's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-1.67% -4.39% 7.69% 6.20% 3.16% -3.88% 4.58% 2.25% 11.28% 9.69% 12.08%
EBITDA Growth
2.58% -1.66% 8.85% 11.81% 7.51% -21.83% 21.49% 7.94% 16.02% 6.97% 16.81%
EBIT Growth
10.08% -0.65% 10.31% 14.40% 9.63% -30.20% 30.34% 10.88% 19.22% 10.20% 16.97%
NOPAT Growth
11.66% -3.42% 11.27% 24.03% 8.36% -29.44% 28.45% 12.74% 15.84% 10.53% 20.66%
Net Income Growth
28.34% 28.78% 14.71% 28.32% 11.54% -34.52% 30.51% 11.99% 20.44% 14.24% 19.57%
EPS Growth
32.03% 36.07% 15.66% 29.58% 14.95% -32.87% 34.79% 17.77% 20.73% 14.67% 21.99%
Operating Cash Flow Growth
-51.03% 160.46% -8.15% -13.49% 25.32% -38.02% 48.43% -23.96% 52.01% 21.47% 18.21%
Free Cash Flow Firm Growth
-74.62% 153.83% -83.56% 98.21% -70.05% -775.07% 181.61% -18.11% 101.44% -28.98% 82.06%
Invested Capital Growth
2.63% -11.27% 9.58% 8.06% 13.48% 21.92% 1.97% 4.66% -0.23% 4.77% 0.21%
Revenue Q/Q Growth
0.74% -1.09% 2.08% 1.55% 0.29% 0.53% -0.27% 0.00% 1.00% 1.25% 3.63%
EBITDA Q/Q Growth
7.73% -0.70% 0.99% 1.13% 2.38% -9.14% 4.26% 0.00% 2.37% -0.80% 3.79%
EBIT Q/Q Growth
11.93% -0.67% 0.81% 1.27% 3.06% -13.71% 6.45% 0.00% 2.75% -0.52% 3.78%
NOPAT Q/Q Growth
13.26% -3.27% 0.85% 5.18% 1.56% -12.29% 6.70% 0.00% 1.24% -0.90% 4.56%
Net Income Q/Q Growth
57.49% -0.65% -0.40% 5.79% 2.18% -14.96% 7.46% 0.00% 3.16% -0.50% 4.12%
EPS Q/Q Growth
59.69% 0.97% -0.21% 6.32% 2.88% -13.98% 8.92% 0.00% 3.14% -0.19% 4.89%
Operating Cash Flow Q/Q Growth
-6.57% -2.57% 22.12% 3.35% 6.33% -1.88% -6.17% 0.00% -2.19% 3.60% 8.69%
Free Cash Flow Firm Q/Q Growth
-27.94% -4.61% 169.99% 49.31% -87.52% -1,813.45% 696.40% -93.15% 113.88% -33.76% 64.78%
Invested Capital Q/Q Growth
-5.50% -5.45% -6.99% -7.85% 5.75% 14.79% 4.02% 0.00% -3.73% 0.58% -4.66%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
35.51% 100.00% 35.26% 36.12% 36.12% 35.18% 37.10% 37.33% 37.51% 36.96% 37.20%
EBITDA Margin
18.68% 19.21% 19.42% 20.45% 21.31% 17.33% 20.14% 21.26% 22.16% 21.61% 22.52%
Operating Margin
14.08% 14.06% 14.32% 15.49% 16.24% 12.08% 15.08% 16.56% 17.03% 16.94% 18.11%
EBIT Margin
14.11% 14.66% 15.02% 16.18% 17.20% 12.49% 15.56% 16.88% 18.08% 18.16% 18.96%
Profit (Net Income) Margin
6.59% 8.88% 9.46% 11.43% 12.36% 8.42% 10.51% 11.51% 12.46% 12.98% 13.84%
Tax Burden Percent
52.86% 69.91% 71.72% 77.41% 77.58% 76.56% 75.32% 75.63% 76.56% 77.57% 78.10%
Interest Burden Percent
88.42% 86.66% 87.84% 91.29% 92.67% 88.10% 89.66% 90.19% 90.01% 92.09% 93.49%
Effective Tax Rate
30.14% 29.32% 28.28% 22.59% 22.42% 23.44% 24.68% 24.37% 23.44% 22.43% 21.90%
Return on Invested Capital (ROIC)
11.45% 11.57% 13.06% 14.89% 14.55% 8.71% 10.08% 11.00% 12.47% 13.48% 15.87%
ROIC Less NNEP Spread (ROIC-NNEP)
-2.09% 7.44% 8.19% 11.63% 13.39% 6.10% 7.98% 8.43% 10.46% 12.70% 14.19%
Return on Net Nonoperating Assets (RNNOA)
-0.81% 3.15% 2.18% 3.14% 4.06% 2.60% 4.47% 4.46% 3.98% 3.47% 3.56%
Return on Equity (ROE)
10.64% 14.71% 15.25% 18.03% 18.61% 11.31% 14.54% 15.46% 16.45% 16.95% 19.43%
Cash Return on Invested Capital (CROIC)
8.85% 23.50% 3.92% 7.14% 1.93% -11.05% 8.12% 6.44% 12.70% 8.82% 15.67%
Operating Return on Assets (OROA)
9.74% 10.26% 10.87% 12.02% 12.19% 7.67% 9.58% 10.09% 11.35% 11.80% 12.99%
Return on Assets (ROA)
4.55% 6.22% 6.85% 8.50% 8.76% 5.17% 6.47% 6.88% 7.82% 8.43% 9.49%
Return on Common Equity (ROCE)
10.64% 14.71% 15.25% 18.03% 18.61% 11.31% 14.54% 15.46% 16.45% 16.95% 19.43%
Return on Equity Simple (ROE_SIMPLE)
11.59% 14.51% 14.07% 18.01% 17.33% 11.27% 14.39% 14.86% 15.23% 16.53% 0.00%
Net Operating Profit after Tax (NOPAT)
217 210 233 289 313 221 284 320 371 410 495
NOPAT Margin
9.84% 9.94% 10.27% 11.99% 12.60% 9.25% 11.36% 12.52% 13.04% 13.14% 14.14%
Net Nonoperating Expense Percent (NNEP)
13.54% 4.13% 4.87% 3.26% 1.16% 2.60% 2.10% 2.57% 2.01% 0.78% 1.69%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 9.90% 10.98% 11.72% 14.17%
Cost of Revenue to Revenue
64.49% 0.00% 64.74% 63.88% 63.88% 64.82% 62.90% 62.67% 62.49% 63.04% 62.80%
SG&A Expenses to Revenue
18.67% 17.96% 18.24% 17.96% 16.97% 17.26% 17.72% 17.43% 17.46% 16.62% 16.25%
R&D to Revenue
2.76% 2.82% 2.70% 2.68% 2.91% 3.13% 3.54% 3.16% 3.01% 2.94% 2.72%
Operating Expenses to Revenue
21.43% 85.94% 20.94% 20.63% 19.89% 23.10% 22.02% 20.59% 20.47% 20.02% 19.10%
Earnings before Interest and Taxes (EBIT)
311 309 341 390 428 299 389 432 514 567 663
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
412 405 441 493 530 414 504 544 631 675 788
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.38 3.24 3.40 2.84 3.31 2.66 2.95 3.21 3.65 5.50 8.02
Price to Tangible Book Value (P/TBV)
0.00 60.91 51.07 329.57 45.97 0.00 0.00 0.00 40.08 75.98 65.85
Price to Revenue (P/Rev)
1.36 1.98 2.29 1.80 2.36 1.99 2.15 2.49 2.99 4.31 5.81
Price to Earnings (P/E)
20.58 22.33 24.19 15.75 19.10 23.58 20.48 21.63 23.97 33.25 41.98
Dividend Yield
0.79% 0.55% 0.48% 0.60% 0.48% 0.59% 0.52% 0.45% 0.36% 0.23% 0.17%
Earnings Yield
4.86% 4.48% 4.13% 6.35% 5.24% 4.24% 4.88% 4.62% 4.17% 3.01% 2.38%
Enterprise Value to Invested Capital (EV/IC)
1.91 2.70 2.97 2.39 2.79 2.06 2.25 2.47 3.08 4.54 6.70
Enterprise Value to Revenue (EV/Rev)
1.66 2.18 2.44 2.00 2.57 2.40 2.56 2.88 3.21 4.53 5.98
Enterprise Value to EBITDA (EV/EBITDA)
8.88 11.34 12.55 9.80 12.05 13.86 12.69 13.55 14.49 20.95 26.54
Enterprise Value to EBIT (EV/EBIT)
11.75 14.86 16.24 12.38 14.93 19.23 16.42 17.07 17.77 24.93 31.54
Enterprise Value to NOPAT (EV/NOPAT)
16.86 21.93 23.75 16.70 20.39 25.97 22.49 23.00 24.64 34.46 42.27
Enterprise Value to Operating Cash Flow (EV/OCF)
22.51 10.86 14.25 14.37 15.16 21.99 16.48 24.98 20.40 25.96 32.51
Enterprise Value to Free Cash Flow (EV/FCFF)
21.80 10.79 79.11 34.82 153.72 0.00 27.91 39.27 24.20 52.68 42.82
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.76 0.75 0.53 0.50 0.51 0.67 0.64 0.63 0.45 0.43 0.38
Long-Term Debt to Equity
0.76 0.63 0.53 0.50 0.51 0.61 0.64 0.53 0.45 0.39 0.30
Financial Leverage
0.39 0.42 0.27 0.27 0.30 0.43 0.56 0.53 0.38 0.27 0.25
Leverage Ratio
2.34 2.37 2.23 2.12 2.12 2.19 2.25 2.25 2.10 2.01 2.05
Compound Leverage Factor
2.07 2.05 1.96 1.94 1.97 1.93 2.02 2.03 1.89 1.85 1.91
Debt to Total Capital
43.16% 42.80% 34.76% 33.25% 33.80% 39.99% 39.20% 38.77% 31.09% 29.98% 27.44%
Short-Term Debt to Total Capital
0.06% 6.67% 0.01% 0.01% 0.00% 3.36% 0.00% 6.26% 0.00% 2.57% 5.73%
Long-Term Debt to Total Capital
43.10% 36.13% 34.76% 33.24% 33.80% 36.64% 39.20% 32.51% 31.09% 27.41% 21.71%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
56.84% 57.20% 65.24% 66.75% 66.20% 60.01% 60.80% 61.23% 68.91% 70.02% 72.56%
Debt to EBITDA
2.31 2.38 1.85 1.55 1.71 2.87 2.34 2.31 1.67 1.55 1.22
Net Debt to EBITDA
1.61 1.02 0.77 0.99 0.97 2.40 2.00 1.84 1.02 0.98 0.74
Long-Term Debt to EBITDA
2.31 2.01 1.85 1.55 1.71 2.63 2.34 1.94 1.67 1.42 0.96
Debt to NOPAT
4.39 4.61 3.49 2.64 2.89 5.39 4.15 3.92 2.83 2.56 1.94
Net Debt to NOPAT
3.06 1.97 1.45 1.68 1.64 4.49 3.54 3.11 1.73 1.62 1.19
Long-Term Debt to NOPAT
4.39 3.89 3.49 2.64 2.89 4.94 4.15 3.28 2.83 2.34 1.53
Altman Z-Score
3.16 3.57 4.02 3.83 3.99 3.19 3.50 3.58 4.50 5.45 6.92
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.44 2.10 2.37 1.96 2.05 1.61 1.78 1.55 2.13 1.69 1.44
Quick Ratio
1.63 1.51 1.64 1.27 1.37 0.97 1.11 1.00 1.41 1.11 0.93
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
168 426 70 139 42 -281 229 188 378 268 488
Operating Cash Flow to CapEx
488.88% 981.85% 846.20% 759.08% 770.97% 586.01% 1,045.97% 1,038.82% 1,261.55% 942.17% 727.63%
Free Cash Flow to Firm to Interest Expense
4.66 10.32 1.69 4.08 1.33 -7.89 5.69 3.99 7.35 5.98 11.32
Operating Cash Flow to Interest Expense
4.51 10.26 9.37 9.90 13.44 7.35 9.63 6.27 8.72 12.13 14.91
Operating Cash Flow Less CapEx to Interest Expense
3.59 9.21 8.27 8.59 11.70 6.09 8.71 5.67 8.03 10.84 12.86
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.69 0.70 0.72 0.74 0.71 0.61 0.62 0.60 0.63 0.65 0.69
Accounts Receivable Turnover
4.15 4.10 4.74 4.43 4.06 3.92 4.05 3.73 3.91 3.98 3.96
Inventory Turnover
3.70 0.00 3.94 3.84 3.75 3.63 3.74 3.58 3.58 3.74 3.80
Fixed Asset Turnover
5.06 5.26 5.83 6.31 6.55 6.26 6.78 7.28 8.42 9.29 9.70
Accounts Payable Turnover
9.02 0.00 8.10 7.37 6.99 7.33 7.62 6.70 6.97 8.01 7.88
Days Sales Outstanding (DSO)
87.85 89.08 76.98 82.38 89.93 93.18 90.19 97.81 93.39 91.67 92.20
Days Inventory Outstanding (DIO)
98.57 0.00 92.58 95.04 97.41 100.51 97.51 101.90 101.93 97.53 96.08
Days Payable Outstanding (DPO)
40.49 0.00 45.07 49.54 52.25 49.83 47.90 54.46 52.38 45.54 46.31
Cash Conversion Cycle (CCC)
145.94 89.08 124.49 127.88 135.09 143.86 139.80 145.25 142.94 143.65 141.96
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,920 1,704 1,867 2,017 2,289 2,791 2,846 2,979 2,972 3,114 3,120
Invested Capital Turnover
1.16 1.16 1.27 1.24 1.16 0.94 0.89 0.88 0.96 1.03 1.12
Increase / (Decrease) in Invested Capital
49 -216 163 150 272 502 55 133 -6.73 142 6.41
Enterprise Value (EV)
3,658 4,595 5,538 4,831 6,389 5,743 6,390 7,364 9,139 14,131 20,914
Market Capitalization
2,993 4,183 5,199 4,344 5,874 4,750 5,383 6,367 8,496 13,467 20,328
Book Value per Share
$27.46 $29.19 $34.62 $34.96 $41.56 $43.07 $46.55 $51.61 $60.89 $64.56 $68.71
Tangible Book Value per Share
($0.61) $1.55 $2.31 $0.30 $2.99 ($6.68) ($4.45) ($4.80) $5.54 $4.67 $8.37
Total Capital
2,209 2,257 2,342 2,293 2,680 2,979 3,004 3,236 3,379 3,499 3,491
Total Debt
953 966 814 763 906 1,191 1,178 1,254 1,050 1,049 958
Total Long-Term Debt
952 816 814 762 906 1,091 1,178 1,052 1,050 959 758
Net Debt
665 412 339 486 515 993 1,007 997 643 664 587
Capital Expenditures (CapEx)
33 43 46 44 55 45 37 28 36 58 88
Debt-free, Cash-free Net Working Capital (DFCFNWC)
464 336 336 381 394 392 402 480 504 459 442
Debt-free Net Working Capital (DFNWC)
753 890 811 657 785 590 573 737 911 844 813
Net Working Capital (NWC)
752 740 811 657 785 490 573 535 911 754 613
Net Nonoperating Expense (NNE)
72 22 18 13 5.81 20 21 26 16 5.07 11
Net Nonoperating Obligations (NNO)
665 412 339 486 515 1,003 1,019 997 643 664 587
Total Depreciation and Amortization (D&A)
101 96 100 103 102 116 114 112 116 108 125
Debt-free, Cash-free Net Working Capital to Revenue
21.05% 15.95% 14.79% 15.79% 15.84% 16.40% 16.07% 18.79% 17.70% 14.69% 12.62%
Debt-free Net Working Capital to Revenue
34.14% 42.21% 35.71% 27.24% 31.55% 24.69% 22.91% 28.84% 32.00% 27.03% 23.24%
Net Working Capital to Revenue
34.08% 35.07% 35.70% 27.23% 31.55% 20.51% 22.91% 20.92% 32.00% 24.15% 17.52%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$3.12 $4.22 $4.86 $6.28 $7.20 $4.83 $6.61 $7.67 $9.26 $10.61 $12.94
Adjusted Weighted Average Basic Shares Outstanding
46.62M 44.39M 44.18M 43.89M 42.74M 41.74M 40.42M 38.39M 38.28M 38.15M 37.42M
Adjusted Diluted Earnings per Share
$3.05 $4.15 $4.80 $6.22 $7.15 $4.80 $6.58 $7.62 $9.20 $10.55 $12.87
Adjusted Weighted Average Diluted Shares Outstanding
47.62M 45.05M 44.76M 44.32M 43.02M 42.00M 40.60M 38.65M 38.53M 38.37M 37.63M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $7.20 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
44.53M 44.53M 44.15M 42.79M 42.71M 40.94M 38.44M 38.27M 38.21M 37.66M 36.87M
Normalized Net Operating Profit after Tax (NOPAT)
217 210 233 289 313 271 298 320 371 421 498
Normalized NOPAT Margin
9.84% 9.94% 10.27% 11.99% 12.60% 11.32% 11.93% 12.52% 13.04% 13.50% 14.24%
Pre Tax Income Margin
12.48% 12.71% 13.19% 14.77% 15.94% 11.00% 13.95% 15.22% 16.27% 16.73% 17.72%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
8.64 7.50 8.22 11.48 13.65 8.40 9.67 9.19 10.01 12.64 15.37
NOPAT to Interest Expense
6.02 5.08 5.62 8.51 10.00 6.22 7.06 6.82 7.22 9.14 11.47
EBIT Less CapEx to Interest Expense
7.71 6.45 7.12 10.18 11.90 7.15 8.75 8.58 9.32 11.35 13.32
NOPAT Less CapEx to Interest Expense
5.10 4.04 4.52 7.21 8.25 4.97 6.14 6.21 6.53 7.85 9.42
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
16.58% 12.31% 11.51% 9.55% 9.17% 13.99% 10.90% 9.78% 8.53% 7.82% 7.17%
Augmented Payout Ratio
218.79% 68.50% 35.77% 81.57% 25.64% 113.31% 141.46% 29.10% 22.68% 69.55% 103.19%

Quarterly Metrics And Ratios for Curtiss-Wright

This table displays calculated financial ratios and metrics derived from Curtiss-Wright's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 36,869,530.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 36,869,530.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 3.48
Growth Metrics
- - - - - - - - - - -
Revenue Growth
14.87% 3.71% 13.05% 11.41% 10.30% 4.90% 12.97% 11.70% 8.79% 14.88% 13.41%
EBITDA Growth
19.26% 8.00% 18.42% 9.91% 7.91% -2.77% 21.61% 20.64% 11.61% 15.03% 18.08%
EBIT Growth
25.34% 8.95% 26.84% 13.86% 11.10% -1.75% 23.42% 21.70% 10.71% 14.63% 24.01%
NOPAT Growth
23.80% 3.90% 26.93% 17.56% 11.10% -3.02% 35.51% 18.85% 14.83% 18.11% 23.82%
Net Income Growth
31.19% 9.96% 34.57% 22.81% 14.86% -1.70% 32.48% 21.70% 12.30% 16.25% 26.49%
EPS Growth
31.41% 9.89% 34.46% 22.86% 15.14% -0.64% 34.67% 23.64% 14.53% 19.42% 29.10%
Operating Cash Flow Growth
53.01% -3.43% 50.18% 0.35% 21.12% 6.70% 15.05% 22.68% 8.78% 17.07% 85.41%
Free Cash Flow Firm Growth
-205.98% 992.35% 166.04% 180.32% 103.46% -117.51% -168.37% -170.05% -146.48% 691.94% 285.08%
Invested Capital Growth
0.00% -0.23% -1.93% -0.95% 0.29% 4.77% 6.44% 6.81% 5.71% 0.21% -1.38%
Revenue Q/Q Growth
2.83% 8.49% -9.24% 10.04% 1.80% 3.18% -2.26% 8.80% -0.84% 8.95% -3.52%
EBITDA Q/Q Growth
12.44% 17.07% -30.74% 20.56% 10.39% 5.49% -13.37% 19.60% 2.13% 8.71% -11.08%
EBIT Q/Q Growth
15.58% 20.26% -34.71% 25.45% 12.78% 6.35% -17.97% 23.70% 2.60% 10.11% -11.27%
NOPAT Q/Q Growth
16.85% 21.67% -37.11% 31.49% 10.43% 6.21% -12.13% 15.32% 6.69% 9.24% -7.87%
Net Income Q/Q Growth
19.48% 23.88% -36.19% 30.04% 11.75% 6.02% -14.01% 19.46% 3.12% 9.75% -6.43%
EPS Q/Q Growth
19.52% 23.90% -36.01% 29.65% 12.02% 6.92% -13.27% 19.03% 3.76% 11.48% -6.23%
Operating Cash Flow Q/Q Growth
31.92% 92.92% -116.16% 343.98% 59.23% 69.96% -112.87% 452.34% 41.19% 82.92% -101.60%
Free Cash Flow Firm Q/Q Growth
-1,721.90% 104.34% 6.67% -4.74% -21.50% -121.95% -316.57% 2.41% 47.91% 379.54% 30.25%
Invested Capital Q/Q Growth
-2.17% -3.73% 4.05% 1.08% -0.95% 0.58% 5.70% 1.43% -1.97% -4.66% 4.04%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
38.86% 38.78% 35.58% 36.20% 37.33% 38.51% 36.30% 37.21% 37.68% 37.53% 36.28%
EBITDA Margin
23.25% 25.09% 19.15% 20.98% 22.75% 23.25% 20.61% 22.66% 23.34% 23.28% 21.46%
Operating Margin
18.30% 20.45% 14.02% 16.42% 18.14% 18.78% 16.04% 17.83% 19.13% 19.19% 17.46%
EBIT Margin
19.27% 21.36% 15.36% 17.52% 19.40% 20.00% 16.79% 19.08% 19.75% 19.96% 18.35%
Profit (Net Income) Margin
13.36% 15.26% 10.73% 12.67% 13.91% 14.30% 12.58% 13.81% 14.36% 14.47% 14.03%
Tax Burden Percent
76.18% 76.43% 77.27% 78.79% 77.40% 76.93% 81.01% 77.22% 77.46% 77.40% 81.25%
Interest Burden Percent
91.05% 93.47% 90.35% 91.84% 92.64% 92.92% 92.50% 93.71% 93.89% 93.65% 94.07%
Effective Tax Rate
23.82% 23.57% 22.73% 21.21% 22.60% 23.07% 18.99% 22.78% 22.54% 22.60% 18.75%
Return on Invested Capital (ROIC)
25.44% 14.95% 10.15% 12.40% 14.00% 14.82% 13.08% 14.08% 15.71% 16.67% 15.65%
ROIC Less NNEP Spread (ROIC-NNEP)
24.51% 14.59% 10.07% 12.15% 13.87% 14.63% 12.62% 14.14% 15.12% 16.08% 15.44%
Return on Net Nonoperating Assets (RNNOA)
10.12% 5.56% 4.11% 4.45% 4.47% 4.00% 3.69% 3.54% 4.06% 4.04% 4.00%
Return on Equity (ROE)
35.55% 20.50% 14.27% 16.85% 18.47% 18.83% 16.77% 17.62% 19.77% 20.71% 19.65%
Cash Return on Invested Capital (CROIC)
-176.26% 12.70% 14.36% 13.78% 13.10% 8.82% 7.46% 7.54% 9.31% 15.67% 17.29%
Operating Return on Assets (OROA)
24.59% 13.40% 10.02% 11.47% 12.86% 13.00% 11.28% 12.69% 13.35% 13.68% 12.95%
Return on Assets (ROA)
17.06% 9.57% 7.00% 8.30% 9.22% 9.29% 8.45% 9.18% 9.71% 9.92% 9.90%
Return on Common Equity (ROCE)
35.55% 20.50% 14.27% 16.85% 18.47% 18.83% 16.77% 17.62% 19.77% 20.71% 19.65%
Return on Equity Simple (ROE_SIMPLE)
15.73% 0.00% 15.72% 15.97% 16.34% 0.00% 16.80% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
101 123 77 102 112 119 105 121 129 141 130
NOPAT Margin
13.94% 15.63% 10.83% 12.94% 14.04% 14.45% 12.99% 13.77% 14.82% 14.86% 14.18%
Net Nonoperating Expense Percent (NNEP)
0.92% 0.36% 0.08% 0.25% 0.13% 0.19% 0.46% -0.05% 0.59% 0.59% 0.21%
Return On Investment Capital (ROIC_SIMPLE)
- 3.64% - - - 3.40% 2.98% 3.29% 3.68% 4.03% 3.61%
Cost of Revenue to Revenue
61.14% 61.22% 64.42% 63.80% 62.67% 61.49% 63.70% 62.79% 62.32% 62.47% 63.72%
SG&A Expenses to Revenue
17.32% 15.78% 18.34% 16.58% 16.19% 15.60% 17.25% 16.64% 15.76% 15.48% 16.08%
R&D to Revenue
3.24% 2.55% 3.22% 2.82% 2.60% 3.13% 2.86% 2.66% 2.69% 2.69% 2.65%
Operating Expenses to Revenue
20.56% 18.33% 21.56% 19.78% 19.20% 19.72% 20.26% 19.38% 18.55% 18.34% 18.82%
Earnings before Interest and Taxes (EBIT)
140 168 110 137 155 165 135 167 172 189 168
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
168 197 137 165 182 192 166 199 203 220 196
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.42 3.65 4.11 4.22 5.05 5.50 4.67 6.79 8.09 8.02 9.54
Price to Tangible Book Value (P/TBV)
112.94 40.08 34.25 30.35 33.61 75.98 39.51 41.52 71.40 65.85 58.34
Price to Revenue (P/Rev)
2.65 2.99 3.34 3.45 4.08 4.31 3.72 5.57 6.06 5.81 6.96
Price to Earnings (P/E)
21.74 23.97 26.14 26.43 30.93 33.25 27.80 40.79 43.99 41.98 49.14
Dividend Yield
0.40% 0.36% 0.31% 0.30% 0.25% 0.23% 0.26% 0.18% 0.17% 0.17% 0.14%
Earnings Yield
4.60% 4.17% 3.83% 3.78% 3.23% 3.01% 3.60% 2.45% 2.27% 2.38% 2.04%
Enterprise Value to Invested Capital (EV/IC)
2.71 3.08 3.39 3.53 4.26 4.54 3.85 5.70 6.48 6.70 7.93
Enterprise Value to Revenue (EV/Rev)
2.97 3.21 3.58 3.67 4.28 4.53 3.95 5.76 6.28 5.98 7.13
Enterprise Value to EBITDA (EV/EBITDA)
13.59 14.49 16.09 16.57 19.40 20.95 18.01 25.80 27.93 26.54 31.45
Enterprise Value to EBIT (EV/EBIT)
16.72 17.77 19.51 19.92 23.15 24.93 21.40 30.59 33.18 31.54 36.98
Enterprise Value to NOPAT (EV/NOPAT)
22.85 24.64 27.08 27.43 31.89 34.46 28.99 41.70 44.80 42.27 49.49
Enterprise Value to Operating Cash Flow (EV/OCF)
18.27 20.40 21.24 22.34 25.11 25.96 23.01 33.03 35.81 32.51 38.03
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 24.20 23.40 25.53 32.58 52.68 53.22 78.16 71.53 42.82 45.53
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.48 0.45 0.44 0.43 0.42 0.43 0.37 0.35 0.38 0.38 0.36
Long-Term Debt to Equity
0.48 0.45 0.40 0.39 0.39 0.39 0.37 0.35 0.38 0.30 0.29
Financial Leverage
0.41 0.38 0.41 0.37 0.32 0.27 0.29 0.25 0.27 0.25 0.26
Leverage Ratio
2.02 2.10 2.02 2.00 1.99 2.01 1.94 1.92 1.99 2.05 1.97
Compound Leverage Factor
1.84 1.97 1.83 1.84 1.84 1.87 1.79 1.80 1.87 1.92 1.85
Debt to Total Capital
32.47% 31.09% 30.61% 29.92% 29.64% 29.98% 27.25% 26.11% 27.69% 27.44% 26.68%
Short-Term Debt to Total Capital
0.00% 0.00% 2.62% 2.57% 2.54% 2.57% 0.00% 0.00% 0.00% 5.73% 5.57%
Long-Term Debt to Total Capital
32.47% 31.09% 27.99% 27.36% 27.10% 27.41% 27.25% 26.11% 27.69% 21.71% 21.11%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
67.53% 68.91% 69.39% 70.08% 70.36% 70.02% 72.75% 73.89% 72.31% 72.56% 73.32%
Debt to EBITDA
1.71 1.67 1.61 1.57 1.54 1.55 1.36 1.30 1.28 1.22 1.17
Net Debt to EBITDA
1.46 1.02 1.09 1.00 0.89 0.98 1.04 0.85 0.98 0.74 0.75
Long-Term Debt to EBITDA
1.71 1.67 1.47 1.44 1.41 1.42 1.36 1.30 1.28 0.96 0.93
Debt to NOPAT
2.87 2.83 2.71 2.61 2.54 2.56 2.19 2.10 2.05 1.94 1.84
Net Debt to NOPAT
2.46 1.73 1.84 1.66 1.46 1.62 1.67 1.37 1.57 1.19 1.18
Long-Term Debt to NOPAT
2.87 2.83 2.48 2.38 2.32 2.34 2.19 2.10 2.05 1.53 1.46
Altman Z-Score
4.03 4.25 4.65 4.76 5.20 5.19 5.06 6.51 6.89 6.62 7.84
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.99 2.13 2.02 2.05 1.98 1.69 1.89 1.95 1.75 1.44 1.52
Quick Ratio
1.21 1.41 1.30 1.34 1.32 1.11 1.19 1.26 1.09 0.93 0.99
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-2,986 130 138 132 103 -23 -94 -92 -48 134 175
Operating Cash Flow to CapEx
1,560.05% 7,155.90% -379.83% 1,014.90% 1,311.88% 1,416.48% -253.80% 697.65% 1,149.35% 958.70% -49.10%
Free Cash Flow to Firm to Interest Expense
-238.97 11.82 13.08 11.74 9.06 -1.94 -9.32 -8.76 -4.58 11.19 17.59
Operating Cash Flow to Interest Expense
11.71 25.76 -4.32 9.93 15.54 25.81 -3.82 12.98 18.39 29.40 -0.57
Operating Cash Flow Less CapEx to Interest Expense
10.96 25.40 -5.45 8.95 14.35 23.99 -5.33 11.12 16.79 26.34 -1.73
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.28 0.63 0.65 0.65 0.66 0.65 0.67 0.66 0.68 0.69 0.71
Accounts Receivable Turnover
0.00 3.91 3.91 3.84 3.74 3.98 3.81 3.72 3.68 3.96 3.78
Inventory Turnover
0.00 3.58 3.38 3.41 3.46 3.74 3.57 3.54 3.46 3.80 3.72
Fixed Asset Turnover
0.00 8.42 8.74 9.01 9.27 9.29 9.46 9.63 9.72 9.70 9.89
Accounts Payable Turnover
0.00 6.97 8.28 8.22 8.90 8.01 8.57 8.53 8.57 7.88 8.80
Days Sales Outstanding (DSO)
0.00 93.39 93.31 95.17 97.56 91.67 95.86 98.21 99.18 92.20 96.54
Days Inventory Outstanding (DIO)
0.00 101.93 107.91 107.01 105.52 97.53 102.12 103.10 105.37 96.08 98.16
Days Payable Outstanding (DPO)
0.00 52.38 44.06 44.40 41.00 45.54 42.57 42.81 42.59 46.31 41.47
Cash Conversion Cycle (CCC)
0.00 142.94 157.16 157.78 162.09 143.65 155.41 158.49 161.96 141.96 153.22
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,087 2,972 3,092 3,126 3,096 3,114 3,291 3,338 3,273 3,120 3,246
Invested Capital Turnover
1.83 0.96 0.94 0.96 1.00 1.03 1.01 1.02 1.06 1.12 1.10
Increase / (Decrease) in Invested Capital
3,087 -6.73 -61 -30 8.81 142 199 213 177 6.41 -45
Enterprise Value (EV)
8,372 9,139 10,492 11,045 13,194 14,131 12,680 19,040 21,200 20,914 25,727
Market Capitalization
7,470 8,496 9,780 10,378 12,589 13,467 11,948 18,413 20,457 20,328 25,113
Book Value per Share
$57.05 $60.89 $62.22 $64.19 $65.03 $64.56 $67.96 $71.95 $67.13 $68.71 $71.38
Tangible Book Value per Share
$1.73 $5.54 $7.46 $8.93 $9.78 $4.67 $8.03 $11.77 $7.60 $8.37 $11.67
Total Capital
3,236 3,379 3,430 3,508 3,540 3,499 3,518 3,670 3,498 3,491 3,589
Total Debt
1,051 1,050 1,050 1,050 1,049 1,049 959 958 969 958 958
Total Long-Term Debt
1,051 1,050 960 960 959 959 959 958 969 758 758
Net Debt
902 643 712 667 605 664 732 627 743 587 614
Capital Expenditures (CapEx)
9.38 3.95 12 11 14 21 15 20 17 37 12
Debt-free, Cash-free Net Working Capital (DFCFNWC)
621 504 631 647 612 459 620 642 600 442 568
Debt-free Net Working Capital (DFNWC)
770 911 969 1,029 1,055 844 846 973 826 813 912
Net Working Capital (NWC)
770 911 879 939 965 754 846 973 826 613 712
Net Nonoperating Expense (NNE)
4.17 2.94 0.74 2.09 0.99 1.26 3.33 -0.35 3.95 3.68 1.42
Net Nonoperating Obligations (NNO)
902 643 712 667 605 664 732 627 743 587 614
Total Depreciation and Amortization (D&A)
29 29 27 27 27 27 31 31 31 31 28
Debt-free, Cash-free Net Working Capital to Revenue
22.04% 17.70% 21.55% 21.50% 19.84% 14.69% 19.28% 19.41% 17.79% 12.62% 15.75%
Debt-free Net Working Capital to Revenue
27.32% 32.00% 33.10% 34.22% 34.24% 27.03% 26.33% 29.44% 24.47% 23.24% 25.27%
Net Working Capital to Revenue
27.32% 32.00% 30.02% 31.23% 31.32% 24.15% 26.33% 29.44% 24.47% 17.52% 19.73%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.53 $3.14 $2.00 $2.60 $2.91 $3.10 $2.69 $3.21 $3.34 $3.70 $3.47
Adjusted Weighted Average Basic Shares Outstanding
38.29M 38.28M 38.25M 38.30M 38.21M 38.15M 37.68M 37.69M 37.43M 37.42M 36.90M
Adjusted Diluted Earnings per Share
$2.51 $3.11 $1.99 $2.58 $2.89 $3.09 $2.68 $3.19 $3.31 $3.69 $3.46
Adjusted Weighted Average Diluted Shares Outstanding
38.56M 38.53M 38.43M 38.50M 38.45M 38.37M 37.85M 37.90M 37.66M 37.63M 37.06M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
38.24M 38.21M 38.30M 38.30M 37.95M 37.66M 37.69M 37.68M 36.87M 36.87M 36.94M
Normalized Net Operating Profit after Tax (NOPAT)
101 123 77 104 115 119 106 121 129 142 130
Normalized NOPAT Margin
13.94% 15.63% 10.83% 13.23% 14.36% 14.45% 13.12% 13.83% 14.89% 15.00% 14.27%
Pre Tax Income Margin
17.54% 19.96% 13.88% 16.09% 17.98% 18.58% 15.53% 17.88% 18.54% 18.69% 17.27%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
11.17 15.31 10.37 12.26 13.59 14.12 13.33 15.90 16.37 15.75 16.87
NOPAT to Interest Expense
8.08 11.21 7.31 9.06 9.83 10.20 10.32 11.47 12.28 11.73 13.04
EBIT Less CapEx to Interest Expense
10.42 14.95 9.23 11.28 12.41 12.30 11.83 14.04 14.77 12.69 15.71
NOPAT Less CapEx to Interest Expense
7.33 10.85 6.17 8.08 8.65 8.38 8.81 9.61 10.68 8.66 11.88
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
8.59% 8.53% 0.00% 7.80% 7.62% 7.82% 0.00% 7.07% 7.08% 7.17% 0.00%
Augmented Payout Ratio
23.08% 22.68% 13.35% 20.68% 44.56% 69.55% 58.64% 64.73% 101.15% 103.19% 91.02%

Financials Breakdown Chart

Key Financial Trends

Here is a concise, trend-focused snapshot of Curtiss-Wright (CW) using the last four years of quarterly statements. The data shows a clear revenue and earnings uptrend into 2025, with continued cash generation and shareholder returns, balanced by ongoing financing activity and modest gross margin variability.

  • Revenue uptrend over four years: Operating revenue rose from about $757.7M in Q4 2022 to $946.9M in Q4 2025, reflecting a steady top-line improvement.
  • Strong year-end earnings growth in 2025: Net income attributable to common shareholders reached $136.998M in Q4 2025, up from $117.852M in Q4 2024, with diluted EPS up to $3.69 from $3.09.
  • Solid operating cash flow helps support returns: Net cash from continuing operating activities was $352.7M in Q4 2025, up from $301.3M in Q4 2024.
  • Dividend per share increasing: Quarterly cash dividends per share rose to $0.24 in 2025 vs $0.21 in 2024, signaling a stronger income stream for investors.
  • Active capital return via buybacks: 2025 featured sizable share repurchases (e.g., about $290.0M in Q3 and about $139.8M in Q4), continuing the program to return capital to shareholders.
  • Gross margin remains in the mid- to high-30s: Gross margins have generally hovered around 37–38% across the period, with some compression in certain quarters as costs fluctuated.
  • Debt and leverage show a steady profile: Long-term debt sits near $0.96B in recent periods, with ongoing debt repayments and occasional issuances, but no dramatic deleveraging or spike observed.
  • Capex remains modest but ongoing: Purchases of property, plant & equipment and related investing activity are present but at a walk-up pace consistent with a manufacturing-focused firm, supporting the business without risking material overhang on cash flow.
  • Financing cash flows are frequently negative due to repayments and buybacks: Net cash from financing activities ran negative in several periods (e.g., Q4 2025 net financing around -$168.3M), reflecting debt repayments and share repurchases that reduce cash on hand.
  • Investing cash flows can be negative due to capital investment: Net cash from investing activities and related investing outlays (capex and acquisitions) remain a drag on near-term cash, as seen in quarterly negatives tied to capex and acquisitions in several periods.

Bottom line: CW demonstrates a resilient four-year uptrend in revenue and earnings, supported by solid operating cash flow and a continued shareholder-return program. Investors should weigh the consistent capital returns and cash generation against ongoing financing outflows and capital investments that temper near-term liquidity.

05/18/26 04:44 PM ETAI Generated. May Contain Errors.

Curtiss-Wright Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Curtiss-Wright's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Curtiss-Wright's net income appears to be on an upward trend, with a most recent value of $484.23 million in 2025, rising from $145.46 million in 2015. The previous period was $404.98 million in 2024. Check out Curtiss-Wright's forecast to explore projected trends and price targets.

Curtiss-Wright's total operating income in 2025 was $633.52 million, based on the following breakdown:
  • Total Gross Profit: $1.30 billion
  • Total Operating Expenses: $668.01 million

Over the last 10 years, Curtiss-Wright's total revenue changed from $2.21 billion in 2015 to $3.50 billion in 2025, a change of 58.6%.

Curtiss-Wright's total liabilities were at $2.69 billion at the end of 2025, a 6.0% increase from 2024, and a 55.0% increase since 2015.

In the past 10 years, Curtiss-Wright's cash and equivalents has ranged from $171.00 million in 2021 to $553.85 million in 2016, and is currently $371.35 million as of their latest financial filing in 2025.

Over the last 10 years, Curtiss-Wright's book value per share changed from 27.46 in 2015 to 68.71 in 2025, a change of 150.2%.



Financial statements for NYSE:CW last updated on 5/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners